NOV Mono expands operation in Germany
Pumps specialist aims to grow Mono Universal Parts across Europe
Svetla Laskova will be located in Berlin and Werner Potrafke will be working near Bochum. Both have language skills and sales and business development experience in the industrial and engineering sectors.
According to Martyn Turner, Universal Parts product manager at Mono, there is a significant market for progressing cavity (PC) pumps in Germany and until recently buyers have had to purchase replacement parts from the OEM.
‘Mono manufactures a range of Universal Parts designed for use in other branded PC pumps and these two new appointments will help us to promote the benefits of the brand and our PC pump technology to the waste water market in Germany,’ he said.
The full range of Mono Universal Parts includes rotors, stators, coupling rods, shafts, pins/bushes, seals and drive train assemblies for use in Seepex, Netzsch, PCM, Allweiler, Robbins & Myers, Bornemann and Orbit pumps.
Based in Manchester, UK, NOV Mono Group has more than 700 authorised distributors worldwide and employs around 750 people.
You may also like
Manufacturing
RION engages Lonza to scale manufacturing exosome based therapeutics
Collaboration leverages RION’s proprietary biomanufacturing process to propel RION’s industry-leading clinical development pipeline towards late-phase trials and commercialisation for multiple regenerative medical conditions
Manufacturing
Quantoom Biosciences partners with Memorial Sloan Kettering Cancer Center to advance personalised mRNA cancer therapeutics
Quantoom Biosciences will use MSK's proprietary lipid nanoparticle technology, Ncapsulate QCX-002, in the development of personalised RNA-based cancer therapies, with plans to support upcoming Phase I clinical trials
Manufacturing
Baxter earns first Gold Resiliency Badge from HIRC across IV, nutrition and premix drug categories
The company is the first manufacturer to receive the Healthcare Industry Resilience Collaborative’s gold badge for IV solutions, nutrition solutions and premix drugs, recognising its leadership in building a transparent, reliable and disruption-ready healthcare supply chain